GRANT BISCHOF: Open Payments
NPI 1306467709 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,438 in 226 payments from 31 companies in 2025. Trend: 2023 $3,362 · 2024 $3,800 · 2025 $15,438
Speaker / faculty: $10,831Food & beverage: $4,331Travel & lodging: $189Education: $87
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $11,446 |
| TG Therapeutics, Inc. | 26 | $757 |
| Teva Pharmaceuticals USA, Inc. | 10 | $357 |
| PFIZER INC. | 19 | $277 |
| Lilly USA, LLC | 6 | $200 |
| Amneal Pharmaceuticals LLC | 13 | $190 |
| EMD Serono, Inc. | 8 | $174 |
| Lundbeck LLC | 7 | $155 |
| Amgen Inc. | 8 | $154 |
| Celgene Corporation | 11 | $152 |
Products named: QULIPTA, UBRELVY, BRIUMVI, NURTEC ODT, AUSTEDO XR, CREXONT, UPLIZNA, ZEPOSIA.
Industry payments across NC — which companies pay providers there.
